tapering

AB1712 ROLE OF ULTRASOUND EVALUATION IN THE PREDICTION OF FLARE IN PATIENTS AFFECTED BY JUVENILE IDIOPATHIC ARTHRITIS DURING THE TRANSITION PHASE
I. Suardi, D. Auteri, O. De Lucia, S. Costi, M. Gattinara, A. Marino, C. Chighizola, R. F. Caporali

Annals of the Rheumatic Diseases Jun 2024, 83 (Suppl 1) 2232-2233; DOI: 10.1136/annrheumdis-2024-eular.5752
AB1569-HPR CLINICAL AND ECONOMIC BURDEN OF POLYMYALGIA RHEUMATICA IN PATIENTS WITH AN INADEQUATE RESPONSE TO GLUCOCORTICOIDS OR GLUCOCORTICOIDS TAPER IN A REAL-WORLD SETTING
J. R. Curtis, L. Araujo, S. Fiore, S. E. Sattui, J. H. Stone, B. Yip, K. Ford, F. Xie

Annals of the Rheumatic Diseases Jun 2024, 83 (Suppl 1) 2157-2158; DOI: 10.1136/annrheumdis-2024-eular.1707
AB1406 ANAKINRA IN THE MANAGEMENT OF ADULT-ONSET STILL’S DISEASE: A SINGLE-CENTER EXPERIENCE
B. Kilic, K. Parlar, A. Ozturk, S. Karup, K. Karaahmetli, Y. Guler, S. Ugurlu

Annals of the Rheumatic Diseases Jun 2024, 83 (Suppl 1) 2056-2057; DOI: 10.1136/annrheumdis-2024-eular.5900
AB1245 AVACOPAN IN ANCA-ASSOCIATED VASCULITIS RECEIVED INTENSIFIED INDUCTION THERAPY WITH CYCLOPHOSPHAMIDE PLUS RITUXIMAB – RETROSPECTIVE OBSERVATION TWO-CENTRE STUDY OF 30 PATIENTS
G. Assmann, A. El-Baraa, K. Peter, T. Ryszard, R. Joerg, M. Schmidt, P. Lamprecht

Annals of the Rheumatic Diseases Jun 2024, 83 (Suppl 1) 1962; DOI: 10.1136/annrheumdis-2024-eular.2573
AB1265 ANALYSIS OF CLINICAL OUTCOMES IN EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA) TREATED WITH MEPOLIZUMAB OVER 2 YEARS FOR REMISSION INDUCTION OR MAINTENANCE: A SINGLE CENTER EXPERIENCE IN JAPAN
Y. Komagata, S. Kawashima, R. Yokota, T. Hibino, Y. Date, K. Usui, J. Yamamoto, N. Ayuzawa, N. Ikegaya, T. Kawakami, M. Kishimoto, S. Kaname

Annals of the Rheumatic Diseases Jun 2024, 83 (Suppl 1) 1975-1976; DOI: 10.1136/annrheumdis-2024-eular.3660
AB1087 POSSIBILITY OF CLINICAL REMISSION AND LOW ACTIVITY IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: REAL-LIFE STUDY
C. Raya-Santos, J. Rosas Gómez de Salazar, A. Pons-Bas, R. Gallego-Campuzano, J. C. Cortés-Quiroz, J. M. Senabre-Gallego, G. Santos Soler, L. Pons-Canet, J. A. Bernal, on behalf of AIRE-MB

Annals of the Rheumatic Diseases Jun 2024, 83 (Suppl 1) 1872; DOI: 10.1136/annrheumdis-2024-eular.3184
AB1023 CONSENSUS-BASED RECOMMENDATIONS FOR GLUCOCORTICOID TAPERING IN SYSTEMIC LUPUS ERYTHEMATOSUS: RATIONALE AND DESIGN OF A MODIFIED DELPHI CONSENSUS PROJECT
G. K. Bertsias, E. M. Vital, A. Doria, S. R. Johnson, S. Mackie, B. Pons-Estel, Y. K. O. Teng, J. Yazdany, S. Navarra

Annals of the Rheumatic Diseases Jun 2024, 83 (Suppl 1) 1830-1831; DOI: 10.1136/annrheumdis-2024-eular.610
AB1079 BELIMUMAB VERSUS PLACEBO IMPROVES DISEASE ACTIVITY AND REDUCES CUMULATIVE GLUCOCORTICOID DOSE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS WHO WERE TREATMENT RESPONDERS: RESULTS OF A LARGE INTEGRATED ANALYSIS
K. Costenbader, M. Aringer, K. Yamaoka, R. A. Levy, J. H. N. Harris, S. Hadlington, A. S. Carroll, W. Stohl

Annals of the Rheumatic Diseases Jun 2024, 83 (Suppl 1) 1867-1868; DOI: 10.1136/annrheumdis-2024-eular.1843
AB0717 GLUCOCORTICOID USE IN RHEUMATOID ARTHRITIS: WHERE ARE WE NOW?
F. M. Ucci, C. Ciancarella, F. R. DI Ciommo, L. DI Sanzo, C. Garufi, R. Scrivo, F. Ceccarelli, C. Alessandri, F. Conti, F. R. Spinelli, On Behalf of Sapienza Arthritis Center

Annals of the Rheumatic Diseases Jun 2024, 83 (Suppl 1) 1649; DOI: 10.1136/annrheumdis-2024-eular.6067
AB0573 EFFICACY OF UPADACITINIB IN RHEUMATOID ARTHRITIS PATIENTS WITH INADEQUATE RESPONSE TO FIRST GENERATION JAK INHIBITORS
M. Kamiya, S. Mori, K. Yamazaki, D. Togawa

Annals of the Rheumatic Diseases Jun 2024, 83 (Suppl 1) 1568-1569; DOI: 10.1136/annrheumdis-2024-eular.1053

Main menu

tapering

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

tapering

Pages